TYPBAR TCV®
Typhoid Vi-PS tetanus toxoid conjugate 0.5ML
What it does
Conjugate is a type of medicine that may be used for various health conditions.
Read more in plain English ↓Plain-language summary for general understanding - not medical advice. Always follow your pharmacist/doctor.
Ask about this medicine
Answers come only from this medicine's registration record, BNF monograph and interaction data - not medical advice.
Medicine sourcing is available in Kenya only. We don't sell or dispense medicines - licensed pharmacies do.
Sourcing - Kenya onlyRegistration & product details
Source: Botswana Medicines Regulatory Authority · fetched 2026-04-15 20:43:13 · updated 2026-10-20 04:32:40
About conjugate
Conjugate is a type of medicine that may be used for various health conditions.
How it works
The exact way conjugate works may depend on the specific condition it is being used for.
Who it's for
Conjugate may be suitable for individuals with certain health issues as determined by a healthcare provider.
AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.
About tetanus
Tetanus is a serious bacterial infection that affects the nervous system and can cause muscle stiffness and spasms.
What it treats
- tetanus infection
- lockjaw
How it works
Tetanus is caused by a toxin produced by the bacteria Clostridium tetani, which interferes with nerve signals to muscles.
Who it's for
Tetanus can affect anyone, especially those who are not vaccinated or have not received booster shots.
AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.
About toxoid
A toxoid is a type of vaccine that helps protect against diseases caused by toxins produced by bacteria.
What it treats
- diphtheria
- tetanus
How it works
Toxoids work by stimulating the immune system to recognize and fight off the bacteria that produce harmful toxins.
Who it's for
Toxoids are generally given to people of all ages, especially children, to help prevent serious infections.
AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.
About typhoid
Typhoid is an infectious disease caused by the bacteria Salmonella typhi, leading to fever and gastrointestinal symptoms.
What it treats
- typhoid fever
- enteric fever
How it works
Typhoid is treated with antibiotics that kill the bacteria causing the infection.
Who it's for
Typhoid treatment is for individuals diagnosed with typhoid fever or those at risk of infection.
AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.
Clinical monograph: conjugate
Conjugates are a class of compounds formed by the chemical linkage of two or more substances, often used in pharmacology to enhance the properties of a drug, such as its solubility, stability, and targeted delivery. Conjugation can occur with various molecules, including proteins, carbohydrates, and nucleic acids, leading to conjugate drugs that can improve therapeutic efficacy and reduce side effects.
Indications
- Cancer therapy
- Autoimmune diseases
- Infectious diseases
- Targeted drug delivery systems
- Vaccination strategies
Dosage
Children: Refer to specific product guidelines for dosing information, as it varies widely based on the conjugate and indication.
Adults: Refer to specific product guidelines for dosing information, as it varies widely based on the conjugate and indication.
Mechanism of action
The mechanism of action of conjugate drugs varies widely depending on the specific substances involved in the conjugation. Generally, conjugation can facilitate drug uptake into cells, enhance bioavailability, and alter the pharmacokinetics of the active drug. Some conjugates are designed to target specific receptors or tissues, thereby improving the specificity and efficacy of the therapeutic effect.
Pharmacodynamics
Pharmacodynamics of conjugate drugs is largely dependent on the nature of the conjugated entities. They may exhibit altered binding affinities, modified distribution profiles, and varying degrees of activity compared to their non-conjugated counterparts. The therapeutic effect could be amplified or diminished based on the conjugation strategy employed, with implications for potency and duration of action.
Pharmacokinetics
Pharmacokinetics of conjugate drugs is influenced by the characteristics of both the parent drug and the conjugated moiety. Factors such as absorption, distribution, metabolism, and excretion (ADME) can be significantly altered. Conjugates may exhibit improved solubility and permeability, leading to enhanced absorption and bioavailability. Metabolic pathways may also be modified, potentially altering the half-life and clearance rates of the drug.
Pregnancy
The safety of conjugate vaccines during pregnancy has not been fully established. Use during pregnancy should be based on the benefit-to-risk assessment.
Breast-feeding
Conjugate vaccines are generally considered safe during breastfeeding. Vaccination can be beneficial for the infant when the mother is immunized.
Storage
Conjugate vaccines should be stored in a refrigerator at 2-8 degrees Celsius and protected from light. Do not freeze.
AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.
Clinical monograph: tetanus
Tetanus is a serious bacterial infection caused by the bacterium Clostridium tetani, which produces a potent toxin affecting the nervous system. The disease is characterized by muscle stiffness and spasms, often beginning in the jaw and neck. It can lead to severe complications and can be fatal if left untreated. Vaccination is the primary method of prevention, and treatment typically involves antitoxins, antibiotics, and supportive care.
Indications
- Tetanus prophylaxis
- Treatment of tetanus infection
- Management of tetanus symptoms
Dosage
Children: Refer to the specific guidelines for tetanus immunoglobulin and other supportive treatments as per clinical protocols.
Adults: Refer to the specific guidelines for tetanus immunoglobulin and other supportive treatments as per clinical protocols.
Mechanism of action
The tetanus toxin binds to the presynaptic membrane of motor neurons and is transported retrogradely to the spinal cord, where it interferes with neurotransmitter release, particularly inhibiting the release of glycine and gamma-aminobutyric acid (GABA), leading to unopposed motor neuron activity and resultant muscle rigidity and spasms.
Pharmacodynamics
Tetanus toxin is one of the most potent toxins known, with effects that can manifest within hours of exposure. The toxin's ability to block inhibitory neurotransmitter release results in a state of continuous muscle contraction, known as tetany. The clinical presentation of tetanus includes trismus (lockjaw), muscle rigidity, and autonomic instability, among others.
Pharmacokinetics
The pharmacokinetics of tetanus toxin are complex due to its high potency and the nature of its action. Following entry into the body, the toxin binds to nerve endings and is internalized, leading to its effects on neurotransmitter release. The half-life of the toxin is not well defined as it does not circulate freely in the bloodstream but acts locally at the neuromuscular junction. Recovery from the effects of the toxin may take weeks to months, depending on the severity of the infection and the treatment provided.
Adverse effects
- Pain at the injection site
- Fever
- Fatigue
- Headache
- Nausea
Precautions
- Ensure patient is up to date with vaccinations
- Monitor for allergic reactions post-vaccination
- Consider history of neurological disorders
Pregnancy
Tetanus vaccination is considered safe during pregnancy and is recommended to protect both the mother and the newborn.
Breast-feeding
Tetanus vaccination is safe during breastfeeding and does not affect the nursing infant.
Storage
Store in a refrigerator at 2–8 degrees Celsius. Do not freeze.
Formulations
- Tetanus toxoid vaccine
AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.
Clinical monograph: toxoid
Toxoids are inactivated toxic compounds produced by certain bacteria that are used as vaccines to induce immunity against the corresponding toxin. They are commonly used in immunization programs to prevent diseases caused by bacterial toxins, such as diphtheria and tetanus. The process of toxoid preparation involves the detoxification of the bacterial toxin through chemical or heat treatment while preserving its immunogenic properties.
Indications
- Diphtheria prophylaxis
- Tetanus prophylaxis
- Pertussis prophylaxis (when combined with other vaccines)
Dosage
Children: Refer to the BNF for Children for specific dosing recommendations for pediatric immunization with toxoids.
Adults: Refer to specific guidelines for each toxoid vaccine, as dosing may vary based on the type of vaccine and individual patient factors.
Mechanism of action
Toxoids work by stimulating the immune system to produce antibodies against the toxin without causing disease. When administered, the immune system recognizes the toxoid as a foreign substance and generates a specific immune response. This includes the production of immunoglobulin G (IgG) antibodies that can neutralize the active toxin if the individual is exposed to the bacteria in the future.
Pharmacodynamics
The pharmacodynamics of toxoids involve the activation of the adaptive immune response. After vaccination, dendritic cells present the antigen to T cells, which then help B cells differentiate into plasma cells that produce specific antibodies. The presence of these antibodies provides immunity against the toxin by neutralizing its effects, thereby preventing the disease associated with the original bacterial toxin.
Pharmacokinetics
Toxoids are typically administered via intramuscular or subcutaneous injection. Following administration, they are gradually taken up by antigen-presenting cells, which then process and present the toxoid to T cells. The immunogenic response can develop over several weeks. The duration of immunity can vary, necessitating booster doses to maintain adequate antibody levels over time.
Adverse effects
- Local reactions at the injection site, such as pain, swelling, or redness.
- Fever.
- Fatigue.
- Headache.
- Allergic reactions in rare cases.
Precautions
- Use with caution in individuals with a history of severe allergic reactions to a vaccine component.
- Monitor patients for allergic reactions post-vaccination.
Pregnancy
Toxoids are generally considered safe during pregnancy; however, consultation with a healthcare provider is recommended.
Breast-feeding
Toxoids are considered safe for use during breastfeeding.
Storage
Store in a refrigerator at 2-8°C. Do not freeze. Protect from light.
Formulations
- Diphtheria toxoid
- Tetanus toxoid
- Pertussis toxoid
AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.
Clinical monograph: typhoid
Typhoid fever is a systemic infection caused by the bacterium Salmonella enterica serotype Typhi. It is typically transmitted through contaminated food and water, leading to gastrointestinal symptoms, fever, and systemic illness. Treatment usually involves antibiotics to eliminate the bacteria and supportive care to manage symptoms.
Indications
- Typhoid fever
- Enteric fever
- Salmonella infections
Dosage
Children: Refer to specific antibiotic guidelines for dosing, as it varies based on the antibiotic used and local resistance patterns.
Adults: Refer to specific antibiotic guidelines for dosing, as it varies based on the antibiotic used and local resistance patterns.
Mechanism of action
Antibiotics used to treat typhoid fever, such as ciprofloxacin and azithromycin, inhibit bacterial DNA gyrase or protein synthesis, respectively, leading to bacterial cell death. These mechanisms target critical bacterial processes, preventing replication and function.
Pharmacodynamics
The pharmacodynamic effects of antibiotics against Salmonella Typhi include bactericidal action, which reduces the bacterial load and alleviates the symptoms of infection. The choice of antibiotic may depend on local resistance patterns, as some strains have developed resistance to commonly used drugs.
Pharmacokinetics
The pharmacokinetics of antibiotics vary. For example, ciprofloxacin is well absorbed orally, with peak plasma concentrations occurring within 1-2 hours. It has a volume of distribution of approximately 2-3 L/kg and is primarily excreted through urine. Azithromycin, on the other hand, has excellent tissue penetration and a long half-life, allowing for once-daily dosing.
Adverse effects
- Gastrointestinal disturbances
- Nausea
- Vomiting
- Diarrhea
- Abdominal pain
- Headache
- Rash
- Fatigue
Precautions
- Use with caution in patients with a history of gastrointestinal disease
- Monitor for potential drug interactions
- Consider risk of antibiotic resistance
Pregnancy
Consult a healthcare provider before use, as safety during pregnancy is not well established.
Breast-feeding
Consult a healthcare provider before use, as safety during breastfeeding is not well established.
Storage
Store in a cool, dry place, away from direct sunlight. Keep out of reach of children.
AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.
This drug in other countries
The same active ingredient registered across other registries we cover - including different brands.
- ADACEL POLIO {DIPHTHERIA TETANUS PERTUSSIS ACELLULAR COMPONENT) AND POLIOMYELITIS (INACTIVATED VACCINE (ADSORBED REDUCED ANTIGENS)} · Ressourcethica
- ADSORBED TETANUS VACCINE BP · Galaxy Pharmaceutical
- ADSORBED TETANUS VACCINE BP 20 DOSE · Galaxy Pharmaceutical
- COGLAVAX (INACTIVATED VACCINE) · Oriana
- COMBE FIVE VACCINE · Galaxy Pharmaceutical
- COMBE FIVE- 10 DOSE (DIPHTHERIA, TETANUS, PERTUSSIS (WHOLE CELL), HEPATITIS B (RDNA) AND HAEMOPHILUS TYPE B CONJUGATE VACCINE (ADSORBED) -10 DOSE) · Galaxy Pharmaceutical
- ADSORBED TD VACCINE 1&10 DOSE IN A VIAL.PURIFIED TETANUS AND DIPTHORIA TOXOID,SUSPENSION FOR INJECTION. · Pt.biofarmajl Pasteur.no 25 Bandung
- ADSORBED TETANUS VACCINE B.P TETANUS TOXOID VACCINE · Serum Institute Of India
- ANTITET(TETANUS ANTITOXIN)SOLUTION FOR INJECTION · Jiangxi Institute Of Biological Product Inc.tingganshan Economic And Technological Development Zone,jian,jiangxi,p.r,china
- DIPHTERIA,TETANUS,HEPATITIS B AND HAEMOPHILUS INFLUENZA TYPE B CONJUGATE VACCINE ADSORBED · Serum Institute Of India
- DIPHTHERIA, TETANUS, PERTUSSIS, HEPATITIS B AND HAEMOPHILUS INFLUENZAE TYPE B CONJUGATE VACCINE, ADSORBED · Serum Institute Of India Pvt. Ltd. S. Nos. 203-205
- HEXAXIM CONJUGATE VACCINE · Sanofi Pasteur
- HAEMOPHILUS_INFLUENZAE_type-B_conjugate 0.5ML-1 DOSE LYOPHILISED INJECTION
- MENAFRIVAC 10 DOSES LYOPHILIZED, POWDER FOR INJECTION
- PREVENAR COMBINATION PRODUCT SUSPENSION FOR INJECTION
- TETANOL 1.5MG/ML INJECTION
- TETANUS-TOXOID NOT LESS THAN 40IU INJECTION
- TETANUS_ANTITOXIN_B.P 1500IU INJECTION
- Abhay TOX · Human Biologicals Institute
- Adsorbed Tetanus Vaccine BP · Biological E.
- BETT · Biological E.
- COGLAVAX
- ComBe Five · Biological E.
- ComBe Five liquid · Biological E.